BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Contur ELN from Accelrys Inc. (ACCL) Powers UK's Largest Trial of Academic Electronic Lab Notebooks


5/23/2012 11:13:00 AM

SAN DIEGO, May 23, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, today announced it is enabling up to 400 scientists at 16 leading universities in the UK to evaluate the low-cost, easy-to-deploy and use Contur Electronic Lab Notebook (ELN) offered by Accelrys' Contur Software subsidiary.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/contur-eln-from-accelrys-powers-uks-largest-trial-of-academic-electronic-lab-notebooks-152767055.html

The program, which runs through the end of September 2012, facilitates growing academic interest in improving quality of research, IP protection and collaboration through the use ELNs. The scalability, rapid deployment and affordable price point of the Contur ELN is making robust ELN deployments a reality for academia.

"The Contur ELN program is the first of its kind in academia," said Thomas Rozlucki, general manager of Contur Software (a subsidiary of Accelrys). "With university interest and investment in ELN technology trending upwards, we are offering UK educational institutions an opportunity to assess an instantly deployable, Cloud and Web-based notebook that captures and protects IP in a secure, collaborative, multidisciplinary environment. Contur ELN's scalability and speed of deployment make it a valuable productivity tool for the academic community."

Supported by the 'Dial-a-Molecule' Grand Challenge Network funded by the UK government's Engineering and Physical Sciences Research Council (EPSRC), the Contur ELN program is the largest multi-institutional academic ELN trial ever undertaken. It is also the first academic ELN trial spanning chemistry, biology and engineering and the only academic trial that enables cross-functional teams to collaborate effectively using a scalable Cloud- and Web-based ELN featuring Accelrys' rich, industry-leading chemistry capabilities.

"The Dial-a-Molecule roadmap identified the collection of high quality reaction data as a key enabler, and adoption of ELNs in academia is a crucial step," said Richard Whitby, professor of organic chemistry at the University of Southampton and principle investigator on the network. "Accelrys' UK Contur ELN program is an important opportunity for academia to evaluate the use of an easy-to-use and deploy ELN supporting collaborative Cloud-based information sharing."

For more information on the Contur ELN academic program for the UK or to find out how to be part of the program if you are affiliated with one of the 16 participating universities, contact Simon Valentine, global head of the academic division at Accelrys. For more information on implementing Contur ELN in an academic environment, register for the webinar, "Advance Academic Research with an Electronic Laboratory Notebook," scheduled for June 20, 5 PM to 6 PM BST.

About Accelrys, Inc.
Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.

About Dial-a-Molecule
Dial-a-Molecule is an EPSRC funded Grand Challenge Network with the 20-40 year aim of making the delivery of novel molecules as quick and easy as it currently is to order a stock chemical, thus enabling many areas of science and industry. See Dial-a-Molecule for more information.

Related Links
Webinar Recording: Implementing Electronic Laboratory Notebooks in an Academic Environment
Case Study: Three Swedish Universities Adopt Centralized ELN to Advance Academic Research
Learn more about the Contur ELN from Accelrys
Learn more about Dial-a-Molecule

SOURCE Accelrys, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->